Zhi Xiao

机构：Shanghai University of Traditional Chinese Medicine, Traditional Chinese Medicine Hospital of Kunshan · ORCID：0000-0001-9974-0487

发表论文 63 篇 · 总被引 1025 次 · h-index 22

代表论文

• Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data (2021 · Clinical Cancer Research · 被引 57)
• Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis (2021 · Frontiers in Oncology · 被引 34)
• SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/β-catenin signaling (2022 · Oncogene · 被引 26)
• Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy (2024 · Scientific Reports · 被引 22)
• Paradoxical effects of DNA tumor virus oncogenes on epithelium-derived tumor cell fate during tumor progression and chemotherapy response (2021 · Signal Transduction and Targeted Therapy · 被引 22)
• Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer (2021 · Clinical Breast Cancer · 被引 18)